skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Mano, M remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1

Sara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Silvia P Neciosup; Max S Mano; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Jifeng Feng; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Tiffany Kunz; Shantha Rao; Lida B Pacaud; Tetiana Taran; Dennis Slamon; Annual CTRC-AACR San Antonio Breast Cancer Symposium (37. 2014 San Antonio, TX)

Cancer Research Baltimore v. 75, abst. S6-01, May, 2015

Baltimore 2015

Acesso online. A biblioteca também possui exemplares impressos.

2
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1) a phase 3, randomised, double-blind, multicentre trial
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1) a phase 3, randomised, double-blind, multicentre trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1) a phase 3, randomised, double-blind, multicentre trial

Sara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Max S Mano; Silvia P Neciosup; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Shantha Rao; Lida Bubuteishvili Pacaud; Tetiana Taran; Dennis Slamon

The Lancet Oncology London v. 16, n. 7, p. 816-829, 2015

London 2015

Acesso online. A biblioteca também possui exemplares impressos.

3
The CMS trigger system
The CMS trigger system
Material Type:
Artigo 		Adicionar ao Meu Espaço

The CMS trigger system

Chinellato, José Augusto, 1950-; Manganote, Edmilson José Tonelli, 1962- Universidade Estadual de Campinas (Unicamp); Universidade Estadual De Campinas

CHINELLATO, José Augusto; MANGANOTE, Edmilson José Tonelli. The CMS trigger system. Journal of instrumentation. Bristol : Institute of Physics Publishing, 2017. Vol. 12 (Jan., 2017), n. art. P010120, p. 1-121. Disponível em: https://hdl.handle.net/20.500.12733/1665118. Acesso em: 18 mai. 2022.

2017

Acesso online

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (2)
  2. Disponível na Biblioteca (2)

Autor/Criador 

  1. Zhang, Q  (2)
  2. Cabaribere, D  (2)
  3. Rao, S  (2)
  4. Buyse, M  (2)
  5. Dreosti, L  (2)
  6. Toi, M  (2)
  7. Slamon, D  (2)
  8. Jiang, Z  (2)
  9. Shen, K  (2)
  10. Andre, F  (2)
  11. Hurvitz, S  (2)
  12. Liu, D  (2)
  13. Neciosup, S  (2)
  14. Lindsay, M  (2)
  15. Burris, H  (2)
  16. Taran, T  (2)
  17. Pacaud, L  (2)
  18. Shao, Z  (2)
  19. Tseng, L  (2)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (1)
  2. 2003Até2008  (1)
  3. 2009Até2012  (1)
  4. 2013Até2015  (3)
  5. Após 2015  (1)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Mano, M
  2. Zhang, Q
  3. Cabaribere, D
  4. Rao, S
  5. Buyse, M

Neste Assunto:

  1. Placebo
  2. Estudos Randomizados
  3. Linguagem
  4. Educação

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.